STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News • 2/24/2026
Summary
New treatment approaches for inflammatory bowel disease (IBD) could provide hope for patients. Additionally, these developments may result in significant financial gains for drugmakers.
Advertisement
Lindy Score Breakdown (V4.2)
48d
Age
1
Sources
from cluster
1160
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1160/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1160/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 48 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients
Stat News • Today
STAT+: Hospitals roll out chatbots, looking to reclaim their role in patients’ health conversations
Stat News • Today
STAT+: Trump goes soft on insurance, and a medical underwriting chart
Stat News • Today
STAT+: Spyre Therapeutics IBD drug shows promise in early trial
Stat News • Today
Opinion: STAT+: Landmines await Vinay Prasad’s successor at the FDA
Stat News • Today
STAT+: GSK advancing ovarian cancer drug mo-rez
Stat News • Today
STAT+: Pharmalittle: We’re reading about a pancreatic cancer pill, FDA rejecting a Replimune drug again, and more
Stat News • Today
STAT+: Revolution Medicines touts ‘unprecedented’ data for pancreatic cancer pill
Stat News • Today
Opinion: What STAT readers think about nutrition education in med school
Stat News • 2 days ago
Opinion: Erectile dysfunction is more than a sexual issue
Stat News • Today